Ganot Ilan
Director
SaleAlert
- Shares
- 3,278
- Price
- $4.12
- Value
- $13,505
SEC EDGAR · Forms 3/4/5Updated through Oct 30, 2026•61 filings
SLDB
Solid Biosciences Inc.
No net buying or selling imbalance over the last 3 months
No net buyers or sellers account for the net balance. There is no cluster of three distinct buyers within 30 days. We found no CEO/CFO purchases over 12 months.
How to read this signal
Only open-market P purchases and S sales count toward the signal. Vesting, options, taxes and gifts remain in the source data but do not trigger alerts. Rule 10b5-1 trades are shown as informational.
3-month balance
$0.00
0 buyers · 0 sellers
12-month purchases
$0.00
0 distinct insiders
12-month sales
$13,505
1 distinct insiders
Highlighted alerts
1
0 Rule 10b5-1 trades treated as informational
Buying cluster · 30 days
Fewer than three distinct buyers
CEO/CFO purchases · 12 months
No executive purchases found
Get SLDB insider trades by API
The same filtered trades as JSON for your scripts, alerts or AI agent, for 5,500+ US companies — plus sentiment, news, financials and breakout setups. Free · every API · 1,000 requests a month · no card required.
SLDB overview: breakout setup, X sentiment and insiders in one page →
Form 4 raw → Raspberry
The value is in what we do not call a signal.
The SEC XML stores every transaction. Raspberry keeps that evidence, reads the footnotes and separates voluntary open-market activity from vesting, option exercises, gifts, tax withholding, stock purchase and dividend reinvestment plans and pre-programmed 10b5-1 trades.
100
Raw transactions
Everything returned by the filing
1
Voluntary view
P/S trades after deterministic checks
100
Administrative noise
Stored, never alerted
83
10b5-1
Shown as informational
SEC ownership XML facts
- Code
- S
- Shares
- 4,374
- Price
- $5.62
- Footnotes
- 4
Restricted stock units ("RSUs") convert into common stock on a one-for-one basis. Includes 2,399 shares of common stock acquired under the Solid Biosciences Inc. Employee Stock Purchase Plan on May 29, 2026. This sale was made to cover withholding taxes following the vesting of previously granted RSUs pursuant to a durable automatic sale instruction letter adopted by Dr. Brooks on August 15, 2024 effecting the sell-to-cover election. The sale does not represent a discretionary trade by Dr. Brooks. The RSUs were granted on October 18, 2023 (the "Grant Date") and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary.
Raspberry interpretation
Informational — no alert
Reason: tax_withholding. The filing footnotes identify tax withholding. The trade is reported under a Rule 10b5-1 plan.
Recent transactions
Voluntary purchases and sales; administrative noise stays hidden.
“Alert” means a voluntary, unscheduled transaction according to the filing; it is not an investment recommendation. Official source: SEC EDGAR.